PFA
CLX icon

Pathway Financial Advisers’s Clorox CLX Stock Holding History

Pathway Financial Advisers’s Portfolio CLX Stock Details CLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-136
Closed -$16.7K – 193
2025
Q3 		$16.7K Buy
+136
New +$16.9K ﹤0.01% 309
2024
Q1 		– Sell
-117
Closed -$16.7K – 457
2023
Q4 		$16.7K Buy
117
+1
+0.9% +$133 0.01% 310
2023
Q3 		$15.2K Buy
+116
New +$17.6K 0.01% 317
2023
Q1 		$98.6K Sell
624
-5,114
-89% -$767K 0.04% 189
2022
Q4 		$805K Buy
+5,738
New +$814K 0.33% 85

Other funds holding CLX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Pathway Financial Advisers's CLX Position: Q4 2025 in Review

Pathway Financial Advisers sold out of Clorox (CLX) in Q4 2025, closing a stake of 136 shares — an estimated $16.7K sold.

Pathway Financial Advisers first reported a position in CLX in Q4 2022 and held it in 5 quarters. The position peaked at $805K in Q4 2022. 1,049 funds tracked by Wall St. Rank hold CLX as of Q4 2025.

  • Pathway Financial Advisers reported no remaining Clorox position as of Q4 2025 after selling out during the quarter.
  • Pathway Financial Advisers sold 136 Clorox shares in Q4 2025, an estimated $16.7K.
  • Pathway Financial Advisers first reported a position in Clorox in Q4 2022 and held it in 5 quarters.
  • Pathway Financial Advisers's Clorox position peaked at $805K in Q4 2022.
  • 1,049 funds tracked by Wall St. Rank held Clorox as of Q4 2025.

Based on Pathway Financial Advisers's 13F filing for Q4 2025, filed 6 Feb 2026.